News Headlines Article

Medicare’s Uncapped Drug Costs Take A Big Bite From Already Tight Budgets
National Public Radio

Three times a week, 66-year-old Tod Gervich injects himself with Copaxone, a prescription drug that can reduce the frequency of relapses in people who have some forms of multiple sclerosis. After living with the disease for more than 20 years, the self-employed certified financial planner in Mashpee, Mass., is accustomed to managing his condition. What he can’t get used to is how Medicare’s coinsurance charges put a strain on his wallet. 

Commands